Cipla trades higher on forming strategic partnership with MSD

21 Feb 2014 Evaluate

Cipla is currently trading at Rs. 372.25, up by 1.05 points or 0.28% from its previous closing of Rs. 371.20 on the BSE.

The scrip opened at Rs. 374.00 and has touched a high and low of Rs. 374.00 and Rs. 371.00 respectively. So far 35705 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 450.00 on 16-Sep-2013 and a 52 week low of Rs. 354.40 on 01-Mar-2013.

Last one week high and low of the scrip stood at Rs. 384.90 and Rs. 370.40 respectively. The current market cap of the company is Rs. 29892.76 crore.

The promoters holding in the company stood at 36.80%, while Institutions and Non-Institutions held 34.39% and 27.67% respectively.

Cipla, India’s second-largest drug maker by market share has formed an India-specific strategic partnership with MSD, one of the world’s leading players in HIV innovative treatment. Within the scope of the partnership, Cipla will have a non-exclusive license to market, promote and distribute MSD’s raltegravir 400mg tablet, under a different brand name in India.

With its history of over 75 years, Cipla has a formidable operation reaching the far corners of the country and therefore is well placed to ensure this key medication reaches the patients who need it. Access to treatment and patient centric approach are cornerstone to this partnership, with this model both companies expect to broaden reach of raltegravir in private and public markets in India. Access to raltegravir is important for patients who require it as part of third line salvage regimen where there are few options left.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. For more than 70 years, Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 170 countries.

Cipla Share Price

1466.15 5.55 (0.38%)
09-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1729.95
Dr. Reddys Lab 1209.45
Cipla 1466.15
Zydus Lifesciences 894.95
Lupin 2181.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×